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Non-human primates are suitable models for preclinical research aimed at cell-replacement therapies. Recently, it has been
reported that Rho-associated kinase inhibitor Y-27632 markedly reduced dissociation-induced apoptosis of human embryonic
stem (hES) cells, and is expected as a novel supplement for hES cell maintenance or differentiation inductions; however, the
effects of the chemical are still to be determined in model animals. Here, we demonstrated the effect of Y-27632 on cynomolgus
monkey ES (cyES) cells. Also, in cyES cells, Y-27632 treatment dramatically improved the efﬁciency of colony formation from
single cells without affecting the pluripotent state and karyotype. Y-27632 supplementation was also effective for feeder-free
culture and differentiation induction. Neural stem cells directly induced from cyES cells could give rise to neurons, astrocytes
and dopamine producing cells. The present result not only suggests that the chemical was effective for improving the culture
system of primate ES cells, but also the similarity between cyES and hES cells regarding the reactions to the chemical, which
might be further evidence that cyES cells are superior models for hES cells.
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Introduction
Embryonic stem (ES) cell therapy is expected to be a highly promising
method of treatment for seriously damaged or disordered tissues and
organs (Hochedlinger and Jaenisch, 2003; Yang et al., 2007), since
ES cells have high proliferative potency and the ability to differentiate
into many kinds of somatic cells, including germ cells. In recent years,
mouse ES (mES) cells have beenused widely as a modelsystem in cell
transplantation and to explore ES cell biology, for example, signal
pathways maintaining stem-ness. While the mouse model provides a
foundation for studying stem cells, many differences between mES
and human ES (hES) cells have been reported (Daheron et al.,
2004; Ginis et al., 2004; Sumi et al., 2004). In particular, mechanisms
of maintenance and the regulation of pluripotency are quite different
between mice and primates. However, the use of hES cells in basic
research has been confronted with major obstacles relating to ethical
and legal restrictions in some countries.
Although hES cells signiﬁcantly differ from mES cells, they closely
resemble those of non-human primates. Furthermore, non-human
primate models of some diseases are expected more closely to
resemble human diseases than existing mouse models (Suemori and
Nakatsuji, 2006). From these, it is reasonable to think that the
non-human primate would be a more suitable model for preclinical
research aimed at cell-replacement therapies (Haruta et al., 2004).
One of the important differences between mES and hES cells is the
vulnerability of single cells to enzymatic digestion (Thomson et al.,
1998; Amit et al., 2000; Watanabe et al., 2007). This characteristic
restrictedtheapplicationoftheprocedurefordifferentiationorintrodu-
cing a transgene that has been developed in mES cells. Recently, it has
been reported that Rho-associated kinase (ROCK) inhibitor Y-27632
markedly reduced dissociation-induced apoptosis of hES cells, and
enabled expansion from single cell (low-density) culture (Watanabe
etal.,2007).Itwasthoughtthatthechemicalmightbethestandardpro-
tocol in both basic science and the clinical use of hES cells; however,
the effects of the chemical are still to be determined in other primates.
To promote preclinical investigation of hES cells, it is indispensable to
study differentiation and transplantation using non-human primate ES
cells based on the same procedure as with hES cells.
Here, we demonstrated the effect of Y-27632 on cynomolgus
monkey ES (cyES) cell cultures. Furthermore, we performed direct
neural stem cell (NSC) induction from cyES cells using Y-27632,
and examined the effectiveness for preparing transplantable cells
through in vitro differentiation.
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Establishment and culture of cyES cells
In the present study, we used an existing cell line (Cyk-1; Teramura et al.,
2007) and a newly established cell line (Cyk-3). The method for cyES cell
establishment and maintenance was previously reported. Brieﬂy, superovulated
oocytes were fertilized by ICSI using freeze–thawed sperm and cultured until
the blastocyst stage in mCMRL medium at 378Ci n5 %C O 2,5 %O 2 and 90%
N2 until the blastocyst stage. After removal of zona pellucida by treatment with
0.05% Pronase (Roche Diagnostics, IN, USA), inner cell masses (ICMs) were
collected by immunosurgery. Isolated ICMs were individually seeded onto
culture dishes containing a layer of mouse embryonic feeder (MEF) cells in
ES medium composed of Knockout-DMEM (Invitrogen Corporation, CA,
USA), 1 mM L-glutamine, 0.1 mM b-mercaptoethanol (both from Sigma–
Aldrich, Inc., MO, USA), and 0.1 mM MEM non-essential amino acid solution
(Invitrogen), and supplemented with 4 ng/ml of human recombinant basic
ﬁbroblast growth factor (bFGF) (Upstate, NY, USA) 20% Knockout Serum
Replacement (KSR, Invitrogen). After 10 days, ICM developed morphologi-
cally into ES cell-like colonies. After the ﬁrst passage, colonies with an ES cell-
like morphology were selected for propagation, characterization and storage.
All manipulations related to sub-cloning or primary passage were performed
by mechanical methods. The cyES cells were maintained in ES medium with
mitotically inactivated MEF, and passaged by the hES cell protocol
(Cameron et al., 2006).
All procedures related to animal treating were approved by the Institutional
Animal Care and Use Committee at Kinki University, Japan.
Observation of the effect of ROCK inhibitor treatment for cyES cell
culture
The cyES cells (Cyk-1) were dissociated into single cells by the treatment with
0.25% trypsin and 0.02% EDTA (Invitrogen) for 3 min, followed by the
addition of fresh media to inhibit further digestion. Then, the cells were col-
lected, resuspended in ES medium and ﬁltered through 40-mm meshes (BD
Biosciences Discovery Labware, MA, USA) in order to obtain a single cell
suspension.
For 5-bromo-20-deoxyuridine (BrdU) incorporation assays, dissociated cyES
cells were seeded at a concentration of 500 cells/cm
2 onto fresh feeder layers in
thepresence oftheROCK inhibitors Y-27632(WakoPureChemicalIndustries,
Tokyo, Japan) or Fasudil (Tocris Bioscience, MO, USA) during the ﬁrst 24 h of
culture. The BrdU incorporation assay was performed using colorimetric BrdU
Cell proliferation Kit (Roche Diagnostics) according to the manufacturer’s
instructions. BrdU incorporations were also observed by immunocytochemical
(ICC) staining with BrdU Labeling and Detection Kit I (Roche Diagnostics).
For live–dead assays, dissociated cyES cells were seeded at a concentration
of 1500 cells/cm
2 onto petri-dishes without feeder layers in the presence of the
ROCK inhibitors Y-27632 or Fasudil. Induced apoptosis was determined by
propidium iodide (PI) staining and by assessing the mitochondrial transmem-
brane potential (DCm) using ﬂuorescent probe Rhodamine123 (R123; Sigma–
Aldrich). Brieﬂy, total cells were collected after 24 h of culture, washed twice
and stained with PI with PI/RNase Staining Buffer (BD Pharmingen, CA,
USA) for 15 min or R123 at 10 mg/ml for 30 min. PI was excited by 488 laser
light and the emission was detected at 650 nm (long pass ﬁlter). R123 was
excited by 488 laser light and the emission was detected at 530 nm. Fluorescent
intensities were observed with a FACS Caliber and the data were analyzed using
Cell Quest (both from Becton Dickinson, CA, USA).
Colony-formation assay on feeder-free cultures
The efﬁciency of colony formation was determined as the percentage of cyES
cell colonies formed and expressed alkaline phosphatase (ALP) activity per
number of cyES cells seeded (500 cells per 35 mm-dish). After culture for 3
days, colonies were ﬁxed with 10% formalin and used for ALP assays. For
feeder-free cultures, cyES cells were maintained on gelatin-coated plates in
the medium conditioned by contact with MEF, as previously reported (Khoo
et al., 2005) with 4 ng/ml of human recombinant bFGF. Y-27632 was added
to the culture medium at 10 mM only on the day of seeding the cyES cells
by passaging, and the medium was changed with ES medium without
Y-27632 after 24 h.
For ALP staining, we used an ALP kit (Sigma–Aldrich) according to the
instructions provided. Colony forming assays were performed using both cell
lines at passage 8–12. Enzymatically digested cyES cells were ﬁltered
through a 40-mm mesh to avoid the contamination of feeder cells or cell aggre-
gates of cyES cells before seeding.
Immunocytochemistry for characterization of ES cells
The cyES cell cultures were ﬁxed in 4% paraformaldehyde in PBS (4% PFA;
pH 7.4). For ICC staining of OCT-4, ﬁxed ES cells were then permiabilized in
0.5% Triton-X (Sigma–Aldrich) diluted in PBS (0.5%PBT) for 5 min, blocked
by incubation in 5% skim milk (Sigma–Aldrich) diluted in PBS for 1 h, and
then incubated with primary antibody overnight at 48C. The antibodies were
anti-OCT-4 rabbit IgG polyclonal antibody (Santa Cruz Biotechnology, Inc.,
CA, USA) diluted 1/100 in 0.1%PBT. For immunostaining of cell-surface mol-
ecules, such as SSEA-4, TRA1-60 and TRA1-81, ﬁxed cells were washed with
0.5% BSA (Sigma–Aldrich) in PBS and blocked by incubation in 5% skim
milk for 1 h. The antibodies were SSEA-4 mouse monoclonal IgG antibody,
TRA1-60 and TRA1-81 mouse monoclonal IgM antibodies (both from Chemi-
con International, Inc,, CA, USA) diluted 1/100 in 0.5% BSA/PBS. For immu-
noﬂuorescence microscopy of OCT-4 immunostained samples, sections were
incubated for 1 h at room temperature with rhodamine-conjugated bovine anti-
rabbit IgG antibody (Santa Cruz Biotechnology) diluted 1/1000 in 0.1% PBT to
detect OCT-4. For observation of SSEA-4, samples were incubated for 1 h at
room temperature with FITC-conjugated goat anti-mouse IgM antibody or
FITC-conjugated goat anti-mouse IgM antibody (Santa Cruz Biotechnology),
and for detection of TRA1-60 and TRA1-81, we used Cy3-conjugated goat
anti-mouse IgM antibody (Chemicon International) as the secondary antibody.
Samples were then washed three times for 10 min each in PBS, and incubated
in DAPI (Vector Laboratories, Ltd, Peterborough, England) to counterstain
chromosomes. These samples were mounted with VECTORSHIELD mounting
medium (Vector Laboratories) to avoid signal reduction.
Chromosome analysis (karyotyping)
The cyES cells at 4 and 12 times passages were arrested in metaphase by
addition of colcemid at 0.02 mg/ml (Sigma–Aldrich) to the culture medium
for 25 min. the cells were treated with 0.25% trypsin and 0.02% EDTA for
3 min. After vigorous pipetting, the single cell suspension was centrifuged
and resuspended in 0.075 M KCL solution at room temperature. After
20 min, the cells were ﬁxed with methanol and acetic acid (3:1) solution.
The cells were washed three times prior to spreading on slides. The chromo-
some slide were prepared by air-drying method, rinsed with distilled water
and stained with 0.01 mg/ml Hoechst 33 258 (Sigma–Aldrich) and 5 mg/ml
of quinacrine mustard. Stained slides were observed by ﬂuorescent microscope
(Leika Microsystems, Wetzlar, Germany).
Induction of teratoma formation
The cyES cells were injected into the peritoneal cavity of severe combined
immunodeﬁcient (SCID) mice (Charles River Laboratories Japan, Inc.,
Kanagawa, Japan). At 30 days post-injection, teratomas were recovered and
embedded in Tissue-tek O.C.T freezing compound (Sakura Finetechnical.
Co., Ltd, Tokyo, Japan). Cryo-sections of the teratomas were produced using
a Cryostat CM1800 (Leica, Heidelberg, Germany) and differentiation capacity
evaluated after staining with hematoxylin and eosin (both reagents from
Sigma–Aldrich). Evaluations of pluripotency were performed using new cell
line Cyk-3, which was established in present study, passaged 14 times by
single cell digestion and treated 10 mM Y-27632 for ﬁrst days of each seeding.
RNA isolation, reverse transcription and quantitative PCR
The cyES cell colonies passaged 8–12 times using 10 mM Y-27632 for ﬁrst
days of each seeding were retrieved mechanically using a glass capillary
pipette to avoid the contamination of feeder cells, and stored in liquid nitrogen
for analysis. Total RNA was extracted using TRIzol (Invitrogen) according to
the manufacturer’s instructions. Single-strand cDNA was prepared from total
RNA using an oligo-dT primer under standard conditions with Superscript
III reverse transcriptase (Invitrogen). The cDNA from each sample was
diluted and used for an RT-PCR-based assay for Nanog, Oct-4 and b-actin.
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Real-time SYBR Premix Ex-TaqTM (TAKARA BIO, Inc., Shiga, Japan) and
following primer sets (listed 50 to 30 in the order of forward primer, reverse
primer): Oct-4, ATTTGGGTAGGTGTTCAGCC, CGCCGCTTACT-
CATGTTCTT; Nanog, TCAGCTACAAACAGGTGAAG, TCACAC-
CATTGCTATTCTTT. PCR ampliﬁcations were performed with the 7700
Real-time PCR System (Applied Biosystems, CA, USA) at 958C for 10 s fol-
lowed by 40 cycles of 958C, 5 s; 608C, 30 s. Reactions were replicated three
times for two different samples independently differentiated and prepared.
All experiments included negative controls consisting of no cDNA for each
primer pair.
Fold changes were calculated relative to control treatment using the 2
2delta–
deltaCt method (Livak and Schmittgen, 2001). b-Actin expression was used as
reference standard to obtain the delta Ct value, and delta–delta Ct values
were calculated by subtracting the delta Ct of the calibrator (mean values of
Y-27632 treated controls) from that of each sample.
Cryopreservation of cyES cells
Dissociated cyES cells were suspended in DMEM containing 20% KSR and
10% dimethyl sulfoxide (DMSO; Wako Pure Chemical Industries) and stored
at 2808C for 2 weeks. As a control experiment, dissociated cyES cells were
cryopreserved by vitriﬁcation method, i.e. cyES cells were dissociated, centri-
fuged and plunged directly into liquid nitrogen using DAP213 (2 M DMSO,
1 M acetamide and 3 M propylene glycol) as a cryoprotectant. Thawed cells
were washed by ES medium, and cultured on feeder-layer in ES medium sup-
plemented with 10 mM Y-27632. The medium was changed to ES medium
without Y-27632 after 48 h. Colony-forming assay was performed by
seeding cyES cells on feeder layer at a density of 500 cells per 35-mm dish.
After culture for 3 days, colonies were ﬁxed with 10% formalin and used for
ALP assays.
Direct induction of NSCs
Dissociated cyES cells (Cyk-3) were placed in a bacterial dish and cultured in
10% fetal calf serum (FCS) supplemented DMEM to induce embryoid body
(EB) for 3 days. Y-27632 was added to the culture medium at 10 mM only
on the day of each seeding, and the medium was changed to ES medium
without Y-27632 after 48 h. The EBs were then dissociated with 0.25%
trypsin and 0.02% EDTA for 3 min, seeded on a bacterial dish and cultured
in NSC induction medium (NSM) composed with DMEM/F-12 (Sigma),
10 ng/ml of bFGF, 20 ng/ml of epidermal growth factor and insulin transferrin
selenium-A solution (ITS-A; Invitrogen) for 6 days (primary stage). After
primary induction, the derivatives were dissociated again by collagenase and
trypsin, washed and cultured in NSM with N2 supplement (Invitrogen) until
aggregates formed (secondary stage). When enlarged spheres were observed,
they were dispersed and cultured under the same conditions as outlined
above. In order to purify the NSC fractions and prevent contamination of the
undifferentiated cyES cells, the treatments were performed at least three times.
To induce neural cells, oligodendrocytes and dopamine producing cells, the
spheres of NSCs were transplanted onto gelatin-coated dishes and cultured in
IMDM (Invitrogen) supplemented with 20% FCS and 10 ng/ml of bFGF for
7 days.
RT-PCR analysis of Musashi-1 was performed using the following primer
sets (listed 50–30 in the order of forward primer, reverse primer): Musashi-1,
CGAGCTCGACTCCAAAACAATTGACC, TCTACACGGAATTCGGGGA
ACTGGTA.
ICCstainingwasperformedusinganti-Musashi-1 rabbitIgGpolyclonalanti-
body (Abcam, Tokyo, Japan), anti-neuronal Class III b-tublin mouse mono-
clonal IgG antibody (TuJ; Abcam), anti-O4 rabbit IgG polyclonal antibody
(Abcam) and anti-tyrosine hydroxylase rabbit IgG polyclonal antibody (TH;
Abcam).Sampleswere thenobservedafter reactionwithFITC-conjugatedanti-
rabbit IgG or rhodamine-conjugated anti-mouse IgG secondary antibody (both
from Santa Cruz Biotechnology). Differentiation studies were performed using
both cell lines maintained as above at passage 14.
Western blot analysis
Cultured cells were collected by scraping, homogenized in SDS buffer (4%
SDS, 125 mM tris–glycine, 10% b-mercaptoethanol, 2% bromophenol blue
in 30% glycerol) then centrifuged at 10 000 g for 10 min at 48C to remove
debris. Aliquots were subjected to polyacrylamide gel electrophoresis in the
presence of SDS (SDS–PAGE) followed by electrotransfer onto PVDF mem-
brane (Hybond-P; Amersham Pharmacia Biotech, Buckinghamshire, UK).
Molecular size was calibrated with Precision plus proteinTM all blue standards
(Bio-Rad; Mississauga, ON, Canada). The blotted membranes were blocked
overnight with Block ace (Dainippon Sumitomo Pharma, Osaka, Japan), then
immuned with objective primary antibody for over-night at 48C. Antibody
incubations and washes were performed in 0.1%Tween-20 in PBS throughout.
Detection was realized by enhanced chemiluminescence with an ECL plus
western blotting detection system (Amersham Pharmacia Biotech) and horse-
radish peroxidase (HRP)-conjugated secondary antibodies (Santa Cruz Bio-
technology). The lumino-labeled membranes were developed using X-Ray
Film Processor. Relative expression levels in each sample were quantiﬁed by
normalizing western blot signals to housekeeping protein b-actin as a ubiqui-
tous component of cytoskeleton.
Statistical analysis of the data
Signiﬁcant difference was detected by one-way ANOVA analysis followed by
Tukey–Kramer multiplecomparison tests. A valueof P , 0.05 was considered
signiﬁcant.
Results
cyES cell preparation for the experiment
We obtained one female cell line (Cyk-3) from four embryos, and per-
formed further experiments using two cell lines. These cell lines main-
tained pluripotency, and expressed pluripotent primate ES cell
markers such as ALP, Oct-4, SSEA-4, TRA1-60 and TRA1-81.
ROCK inhibitors promote cyES cell survival after single cell
digestion, but did not cause cell proliferation
First, we demonstrated the effect of ROCK inhibitors Y-27632 and
Fasudil on cultures of cyES cells.
Y-27632 promote the numbers of cells proliferated after passage by
single-cell digestion in a dose-dependent manner when observed by
BrdU incorporation assay. BrdU-positive cells increased signiﬁcantly
when 10 or 20 mM Y-27632 was added. In contrast, high amounts (5–
20 mM) of Fasudil treatment resulted in dose-dependent decrease in
proliferated cells (Fig. 1), although Y-27632 did not show toxic
effect even when it was added at 60 mM (data not shown). From the
experiment, the positive effect of ROCK inhibitors on cyES cell via-
bility and the toxicity of high-dose Fasudil were clearly demonstrated.
To determine whether the effect of ROCK inhibitors prevent cell
death of digested cells or promote proliferation after seeding, we per-
formed live–dead staining and BrdU assay following conventional
passages and ROCK inhibitor treatment. The surviving cells were
increased at conditions of 1, 5, 10 mM Y-27632 or 1, 5 mM Fasdil
additions (Fig. 2A and B). On the other hand, the results of BrdU
assay following Y-27632 treatment to attached cyES cells elucidated
that the inhibitor did not result promoting cell proliferation but pro-
tecting cyES cells from cell death after single cell digestion (Fig. 2C).
Inhibition of ROCK for a day does not affect the pluripotency
of cyES cells
In order to examine whether the undifferentiated state of cyES cells
was maintained when they were expanded by single-cell digestion
using ROCK inhibitor Y-27632, we determined the expression of
primate ES cell markers ALP, OCT-4, SSEA-4, TRA1-60 and
TRA1-81. As shown in Fig. 3A and B, these pluripotent state-speciﬁc
markers were expressed. To further examine the pluripotency of cyES
cells treated with Y-27632, we injected the cyES cells into SCID mice.
These cells generated teratomas in 4 weeks; histological examination
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including neural tissue, cartilage, muscular tissue and intestine-like
structure (Fig. 3C–H). Furthermore, 92% of total cells maintained
normal female karyotype for 40XX, and any chromosomal abnormal-
ities such as translocations or inversions were not observed after eight
single-cell digestion passages (Fig. 3I). These results suggest that
Y-27632 treatment enhances cell survival without affecting their plur-
ipotency and chromosomal normality.
The numbers of colonies were signiﬁcantly increased in feeder-free
cultures by the addition of Y-27632 (Fig. 4A). Same results were
observed in different two cell lines Cyk-1 and Cyk-3, Oct-4 and
Nanog mRNA expressions were also maintained after ﬁve times pas-
saging without feeder cells (Fig. 5).
cyES cells were successfully cryopreserved by the addition
of Y-27632
The addition of Y-27632 enables cyES cells to survive after cryopre-
servation with DMSO and 2808C conditions. Approximately 45–
80% of cryopreserved cells survived in Cyk-1 and Cyk-3. No signiﬁ-
cant differences were observed between DMSO/2808C storage and
vitriﬁcation in the case of Cyk-3. In contrast, signiﬁcantly fewer colo-
nies formed when the cells treated without Y-27632. In total, 10–30%
cells survived and formed colonies (Fig. 4B).
Real-time PCR analysis revealed that the expression of
pluripotency-related genes, Nanog and Oct-4, were maintained in
both cases (Fig. 5).
NSC induction from cyES cells
We induced NSCs using Cyk-3 maintained in Y-27632-added
medium. In some cases, ES-cell differentiation induction was
performed through EB formation, which is a spontaneously aggre-
gated structure mimicking the developing embryo. In mice, EBs
were induced by non-adherent culture of dispersed cyES cells.
In the present study, Y-27632 dramatically improved cell aggrega-
tion and enlargement in the primary stage. On the other hand, almost
no aggregates were obtained if the cells were induced differentiation
without Y-27632 (data not shown). The induced NSCs expressed
NSC marker Musashi-1 in the undifferentiated state. Furthermore,
multiple differentiation potentials of cells were determined by differ-
entiation induction to neural cells, oligodendrocytes and dopamine-
producing cells. The differentiated cells expressed TuJ as a neural
cell marker, TH as a dopamine-producing cell marker, and O4 as an
oligodendrocyte marker. Signiﬁcant increase in the expression of
TuJ was also determined observed by western blot analysis
(Fig. 6B-d).
Discussion
Here, we demonstrated that Y-27632 promotes survival of cyES cells,
and it enabled expansion from single cells without losing pluripotent
characteristics. The cyES cells maintained the expression of undiffer-
entiated markers ALP, OCT-4, SSEA-4, TRA1-60 and TRA1-81, and
represented the potential of teratoma formation, which consisted with
all three embryonic germ layers. These results were consistent with the
results of hES cells, suggesting that reactions to the chemical might be
preserved in primates. Furthermore, Y-27632 supplementation
enables cyES cell expansion also in feeder-free culture. The cyES
cells are traditionally cultured on feeder cells derived from mouse
fetus. Feeder cells provide secreted factors, extracellular matrix, and
cellular contacts for the maintenance of ES cells in the undifferen-
tiated state without losing pluripotency; however, feeder cells may
possess a risk of cross-contamination, such as passing animal patho-
gens to hES cells. Feeder-free stem cell culture is a system for main-
taining stem cells in the undifferentiated state without the need for
direct contact with feeder cells, and is expected as a prominent
method for hES cell-based therapy. The result, that chemical additions
dramatically improved the rate of colony formation in feeder-free
culture suggests that primate ES cell adhesion and proliferations,
which were brought about by animal sources, might be alternatively
complemented by the chemical, and it might be an important factor
to realize the establishment of fully chemically deﬁned culture
systems.
To apply ES cell technology to practical medicine, passaging or
differentiation induction procedures should be simple and easily
reproducible, since all procedures relating to medicine are needed to
be performed in accordance with the international cGMP (Current
Good Manufacturing Practice) and GTP (Good Tissue Practice) guide-
lines. However, some differentiation protocols were performed
through EB formation, and primate EBs are ordinarily induced by
hanging drop (Galli et al., 2003; Fujioka et al., 2004), which includes
handling procedures, and may induce the risk of contamination. In the
present study, we examined direct differentiation induction of NSCs
by single-cell digestion and suspension culture in a bacterial dish
using Y-27632.
NSCs are self-renewing, multipotent cells that generate neurons,
astrocytes, and oligodendrocytes (Gage, 2000; Geschwind et al.,
2001). They have great potential as a therapeutic tool for the repair
of a number of central nervous system (CNS) disorders. Potential
targets of NSC transplants include stroke, spinal cord injury, and neu-
rodegenerative diseases, such as Parkinson’s disease (Imitola et al.,
2004;Takagi et al.,2005; Sharma et al.,2007). However, the technical
and ethical difﬁculties in obtaining sufﬁcient and appropriate donor
tissue have limited the application of this therapy, and they are an
Figure1: Effect of ROCKinhibitorfor cyEScell repopulationafter single-cell
digestion.
(A) Dose-dependent effect of two kind of ROCK inhibitors Y-27632 and
Fasudil. Different characters indicate statistically signiﬁcant difference (P ,
0.01) determined by ANOVA and Tukey–Kramer multiple comparison tests.
Data represent the mean+SD of six experiments. (B) Immunocytochemical
observation of BrdU incorporation to cyES cells maintained with/without
10 mM Y-27632.
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(A) Flow cytometric observation after single-cell digestionand culturewithout(a) or with (b) Y-27632. Live/deadevaluationswere performedusingRhodamine123
(R123; left) and propidium iodide(PI; right). (B) Percent of live cells on the FACS-based assay using R123 (a) and PI (b). Values represented the percentage of R123
positive or PI negative cells in total cells. Signiﬁcant differences were observed among all experiment groups (P , 0.01). Data represent the means+SD of six
experiments. (C) BrdU incorporation assay for attached cyES cells passaged by mechanical method. Signiﬁcant difference was not observed (P , 0.05). Data rep-
resent the means+SD of six experiments.
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ability to generate these neurons is unstable. Neural precursor cells
from ES cells are expected to be candidates for use as potential
donor cells for transplantation (Barberi et al., 2003; Ben-Hur et al.,
2004; Keirstead et al., 2005; Takagi et al., 2005; Fukuda et al.,
2006). Y-27632 supplementation was effective for cyES cell survival
also under differentiation conditions, and the number of aggregates
dramatically increased. NSCs were obtained in the secondary induc-
tion stage, in which ﬂoating cell clusters called neurospheres were
found. These spheres expressed undifferentiated NSC marker
Figure 3: Evaluation of pluripotency of Y-27632 treated cyES cells (cyES
cells).
(A) Low-density culture of dissociated cyES cells in the presence or absence of
10 mM Y-27632 on MEF cells. Almost all colonies were positive for ALP. (B)
Characteristics of Y-27632-treated cyES cells (Cyk-3) in undifferentiated state.
These ﬁgures include immunocytochemical staining of Y-27632-treated cyES
cell colonies with anti-OCT-4, anti-SSEA-4, anti-TRA1-60 and anti-TRA1-81
antibodies. (C) Teratoma derived from Y-27632 treated cyES cells. Cells were
transplanted into kidney capsule of SCID mouse. Bar ¼ 1 cm. (D–H) Hema-
toxylin and eosin staining of teratoma derived from cyES cells (Cyk-3). (D)
Neural tissue (ectoderm), (E) Cartilage (mesoderm), (F) smooth muscle(meso-
derm), (G) skeletal muscle (mesoderm) and (H) intestine-like structure (endo-
derm). (I) Karyotyping of cyES cells (Cyk-3) passaged after 12 times
single-cell digestion passages using Y-27632. DIC, differential interference
contrast; ALP, alkaline phosphatase.
Figure 4: Effect of Y-27632 treatment to cyES cell colony formation.
(A) Number of ALP-positive colonies cultured in the absence/presence of
10 mMY-27632withoutfeeder cells(*P , 0.001,n ¼ 3).(B)Numberof ALP-
positive colonies cultured in the absence/presence of 10 mM Y-27632 after
cryopreservation by DMSO-added cryoprotectant or vitriﬁcation method
using DAP213 (*P , 0.01, n ¼ 3).
Figure 5: Quantitative RT-PCR-based evaluation of pluripotency-related
genes Oct-4 and Nanog.
The relative expression values were calculated by delta–delta Ct method using
the mean value of Y-27632 treated controls as a calibrator (control). The
between group differences were evaluated by ANOVA. cyES cells cultured
in Y-27632 supplemented ES medium, white rectangles; cyES cells cultured
in Y-27632 supplemented and feeder-free condition, striped rectangles; cyES
cells expanded after cryopreservation by vitriﬁcation method and stored in
liquid nitrogen (LN), shaded rectangles; cyES cells expanded after cryopreser-
vation using DMSO and stored at 2808C.
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632Musashi-1 in the unattached state. They differentiated by adhesion to a
gelatin-coated dish, giving rise to neurons, oligodendrocytes and
dopamine-producing cells. Spheres passaged ﬁve times also retained
multilineage potential (data not shown). These results suggest that
the NSCs that induced the present systems were functional, and
Y-27632 was a superior supplement, not only for the maintenance
of pluripotent ES cells, but also for the induction of EBs.
Another feasible result of Y-27632 supplementation was that it
enabled cryostorage by the conventional method using DMSO
in 2808C conditions, as for mES cells. Ordinarily, primate ES cells
could be cryopreserved when treated as cell clumps and stored by
vitriﬁcation in liquid nitrogen. On the other hand, only 0.4% of cells
survived if stored by standard slow-rate cooling methods using
DMSO (Fujioka et al., 2004). Interestingly, signiﬁcant improvement
was observed in the rates of colony formation from cryopreserved
cells when cells were treated with Y-27632. In the case of Cyk-3, a
signiﬁcant difference was not observed between the experimental
group using DMSO and vitriﬁcation when supplemented with
Y-27632, and almost all cells survived and formed colonies (80%
of total cells) in both methods. Cryostorage using DMSO and
Y-27632 enables easier and safer shipping of primate ES cells
between research facilities. Furthermore, it may avoid the many
risks considered in a original method.Liquid nitrogen storage was pro-
blematic in itself,because tankinsulation was inefﬁcient and there was
a potential risk for microbial contamination such as hepatitis B when
stored together with contaminated samples (Chen et al., 2006).
In conclusion, we demonstrated the effectiveness of Y-27632 sup-
plementation to primate ES cell culture, differentiation induction
and cryostrage. The present result that cyES cells showed the same
reactions to the chemical as hES cells might provide further evidence
that cyES cells would be superior models for hES cells. This technol-
ogy may accelerate translation of the method developed using mES
cells to preclinical stages.
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